(Press-News.org) Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions like schizophrenia or depression.
Remembering a code for long enough to type it in; holding a conversation and reacting appropriately to what is being said: in everyday situations like these, we use our working memory. It allows a memory to be actively retained for a few seconds. Certain conditions, such as schizophrenia or depression, as well as ADHD, impair working memory. Those affected lose track in conversations and struggle to organize their thoughts.
Fampridine is a drug that could help in such cases, as researchers led by Professor Andreas Papassotiropoulos and Professor Dominique de Quervain at the University of Basel have shown. The team has reported their findings in the journal Molecular Psychiatry.
Effective only if working memory is poor
In their study, the researchers tested the effectiveness of fampridine on working memory in 43 healthy adults. It was in those participants whose baseline working memory was at a low level that fampridine showed a more pronounced effect: after taking the active substance for three days, they scored better in the relevant tests than those who took the placebo. In contrast, in people who already had good baseline working memory, the drug showed no effect.
The researchers also observed that fampridine increased brain excitability in all participants, thus enabling faster processing of stimuli. The study was randomized and double-blind.
Established drug, new application
“Fampridine doesn’t improve working memory in everyone. But it could be a treatment option for those with reduced working memory,” explains Andreas Papassotiropoulos. Dominique de Quervain adds: “That’s why, together with researchers from the University Psychiatric Clinics Basel (UPK), we’re planning studies to test the efficacy of fampridine in schizophrenia and depression.”
The drug is currently used to improve walking ability in multiple sclerosis (MS). Particularly in capsule form, which releases the active ingredient slowly in the body, fampridine has shown effects on cognitive performance in MS patients: for some, it alleviates the mental fatigue that can accompany MS.
The researchers did not select the drug at random: this study followed comprehensive analyses of genome data in order to find starting points for repurposing established drugs. Fampridine acts on specific ion channels in nerve cells that, according to the researchers’ analyses, also play a role in mental disorders such as schizophrenia.
END
Multiple sclerosis drug may help with poor working memory
2024-11-18
ELSE PRESS RELEASES FROM THIS DATE:
The MIT Press releases workshop report on the future of open access publishing and policy
2024-11-18
Cambridge, MA (November 18, 2024) – Today the MIT Press is releasing a workshop report on what additional information is needed to ensure that open access publication benefits research, entitled "Access to Science & Scholarship 2024: Building an Evidence Base to Support the Future of Open Research Policy." The report is the outcome of a workshop funded by the National Science Foundation and held at the D.C. headquarters of the American Association for the Advancement of Science on September 20, 2024.
The implementation of open access has resulted in consolidation of the publishing industry, an explosion in unreviewed articles, and new costs that may be hard ...
Why substitute sugar with maple syrup?
2024-11-18
Quebec, CA, November 18, 2024 – A new study published in the The Journal of Nutrition, found that substituting two tablespoons of pure maple syrup for refined sugars reduced several cardiometabolic risk factors in humans. It was the first placebo-controlled clinical trial exploring potential health benefits of maple syrup in humans.
“We know from decades of research that maple syrup is more than just sugar. It contains over 100 natural compounds, including polyphenols, that are known to prevent disease in part through their anti-inflammatory ...
New study investigates insecticide contamination in Minnesota’s water
2024-11-18
MINNEAPOLIS / ST. PAUL (11/18/2024) — A new study by researchers at the University of Minnesota Twin Cities in collaboration with the Minnesota Department of Natural Resources (DNR) found that specific insecticides, called neonicotinoids, were found at high concentrations in some ground and surface water sources that could affect drinking water.
Individuals relying on shallow groundwater or natural springs for drinking water have a higher risk of contamination from these insecticides compared to those getting their drinking water from deep groundwater wells. ...
The Einstein Foundation Berlin awards €500,000 prize to advance research quality
2024-11-18
The €500,000 Einstein Foundation Award for Promoting Quality in Research honors researchers and institutions whose work helps to fundamentally advance the quality and robustness of research findings. The award is bestowed jointly with the QUEST Center for Responsible Research, Berlin Institute of Health (BIH) at Charité. „The Einstein Foundation Award seeks to amplify the importance of quality and accountability in research, particularly as science plays a critical role in addressing global challenges,“ explains Martin Rennert, Chair of the Einstein Foundation’s Executive Board. ...
Mitochondrial encephalopathy caused by a new biallelic repeat expansion
2024-11-18
Mitochondrial diseases are among the most prevalent hereditary metabolic disorders, known to occur in one out every 5000 births. Single nucleotide variations, indels, and structural variations are known to cause these disorders. While many arise from single nucleotide variations, indels, or structural variants, some forms are also triggered by repeat expansions in nuclear genes affecting mitochondrial function, which can result in severe mitochondrial dysfunction. These diseases often impact the central nervous system (CNS), and mitochondrial encephalopathies represent a subset characterized by prominent ...
Nanoplastics can impair the effect of antibiotics
2024-11-18
Minuscule particles of plastic are not only bad for the environment. A study led from Umeå University, Sweden, has shown that the so-called nanoplastics which enter the body also can impair the effect of antibiotic treatment. The results also indicate that the nanoplastics may lead to the development of antibiotic resistance. Even the indoor air in our homes contains high levels of nanoplastics from, among other things, nylon, which is particularly problematic.
"The results are alarming considering how common nanoplastics are and because effective antibiotics for many can be the difference between life and death," says Lukas Kenner, ...
Be humble: Pitt studies reveal how to increase perceived trustworthiness of scientists
2024-11-18
How can scientists across climate science, medical and psychological topics foster the public’s trust in them and their science? Show that they are intellectually humble.
Those are some of the findings of two intellectually humble University of Pittsburgh scientists and their co-authors, using five separate studies totaling 2,034 participants in research published Nov. 18 in Nature Human Behaviour.
“Research has shown that having intellectual humility — which is an awareness that one’s knowledge or beliefs might be incomplete or wrong — is associated with engaging in more effortful and less biased information processing,” said Jonah Koetke, ...
Promising daily tablet increases growth in children with dwarfism
2024-11-18
A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study. And the findings could spare these children from needing to have a daily injection to boost growth.
The phase II study, led by Murdoch Children’s Research Institute (MCRI) and published in the New England Journal of Medicine, found the drug infigratinib, an investigational product, was safe and effective in treating children with achondroplasia aged 3-11 ...
How 70% of the Mediterranean Sea was lost 5.5 million years ago
2024-11-18
Mediterranean Sea dropped during the Messinian Salinity Crisis – a major geological event that transformed the Mediterranean into a gigantic salt basin between 5.97 and 5.33 million years ago2.
Until now, the process by which a million cubic kilometres of salt accumulated in the Mediterranean basin over such a short period of time remained unknown. Thanks to analysis of the chlorine isotopes3 contained in salt extracted from the Mediterranean seabed, scientists have been able to identify the ...
Keeping the lights on and the pantry stocked: Ensuring water for energy and food production
2024-11-18
A new study, focused on a remote region of the Peruvian Andes where the waters of the Amazon originate, carries lessons for hydropower operators and farming communities worldwide: collaborating on sustainable land management is the best decision they can make for the long-term viability of their businesses and livelihoods. It also opens opportunities for restoration of degraded ecosystems. Research from the Stanford-based Natural Capital Project (NatCap) in Communications - Earth & the Environment integrates hydropower operations with ...